The largest database of trusted experimental protocols

Prl tk renilla luciferase vector

Manufactured by Promega
Sourced in United States

The PRL-TK Renilla luciferase vector is a plasmid that expresses the Renilla luciferase reporter gene under the control of the thymidine kinase (TK) promoter. Renilla luciferase is an enzyme that catalyzes the oxidation of coelenterazine, resulting in the emission of light. This vector is commonly used in various applications that require the monitoring of gene expression or reporter assays.

Automatically generated - may contain errors

94 protocols using prl tk renilla luciferase vector

1

Validation of SIRT1 3' UTR-Luciferase Reporter Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
SIRT1 3’ UTR fragment sequence containing the predicted binding site paired with miR-124 was amplified and cloned into the downstream of firefly luciferase gene in the pMIR-REPORT™ miRNA Expression Reporter Vector (Thermo Fisher Scientific, Inc.) according to the manufacturer’s instruction. The recombinant plasmid was named as pMIR-wtSIRT1. To conduct the mutant SIRT1 3’ UTR-luciferase reporter plasmid, QuikChange Site-Directed Mutagenesis kit (Stratagene, USA) was used based on the pMIR-wtSIRT1 plasmid according to the manufacturer’s instruction. The recombinant plasmid was named as pMIR-mtSIRT1. To perform the luciferase reporter assays, cells were co-transfected with the pMIR plasmid, Renilla luciferase pRL-TK vectors (Promega, USA) and the miR-124 mimics by using the lipofectamine 2000. 48 h after incubation, luciferase activities were measured by using Dual-Luciferase Reporter assay system (Promega) according to the manufacturer’s instruction.
+ Open protocol
+ Expand
2

Verification of miR-125b Targeting HAX-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bioinformatics analysis using TargetScan (http://www.targetscan.org/) indicated that HAX-1 represents a target gene of miR-125b. To verify this, the wild-type of the putative miR-125b binding sites of HAX-1 3′-UTR were cloned into the downstream of firefly luciferase gene in the pMIR-REPORT™ miRNA Expression Reporter Vector (Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. To mutate the seed region of the miR-125b-binding sites (CUCAGGG to CUCUAGG), the QuikChange Site-Directed Mutagenesis kit (Agilent Technologies, Inc., Santa Clara, CA, USA) was used based on the wild-type conducted pMIR-REPORT™ vector following the manufacturer's protocol. To perform the luciferase reporter assay, the MCF-7/R cells were incubated in 48-well plates overnight at 37°C. The cells were then co-transfected with the wild-type (or mutant-type) of pMIR-REPORT vectors, Renilla luciferase pRL-TK vectors (Promega Corporation, Madison, WI, USA), and the miR-125b mimics using Lipofectamine 2000. After 48 h of transfection, the cells were collected and lysed using a lysis buffer provided by Promega Corporation (cat no. E1910). Luciferase activity was then measured using a Dual Luciferase Reporter Assay system according to the manufacturer's protocol (cat no. E1910, Promega Corporation). The relative Firefly luciferase activity was normalized to Renilla luciferase activity.
+ Open protocol
+ Expand
3

Validating PPAR-γ miR-128 Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Partial fragments of PPAR-γ 3′UTR containing predicted miR-128 binding sites were amplified by PCR and subcloned into pGL3-control vectors (Promega, Madison, WI, USA) to generate wild-type (WT) PPAR-γ reporter. Moreover, mutant type (MUT) PPAR-γ reporter with mutant miR-128 binding sites was produced using Quickchage Multi Site-Directed Mutagenesis kit (Stratagene, Lajolla, CA, USA). Next, constructed WT-PPAR-γ or MUT-PPAR-γ reporter was co-transfected into MCN and N2a cells together with control Renilla luciferase pRL-TK vectors (Promega) and miR-Control or miR-128. At 48 h after transfection, relative luciferase activity was determined via dualluciferase reporter assay (Promega).
+ Open protocol
+ Expand
4

Regulation of FOXO1 by miR-374a

Check if the same lab product or an alternative is used in the 5 most similar protocols
FOXO1 3′-UTR containing putative miR-374a binding site was cloned into the downstream of firefly luciferase gene in the pMIR-REPORT™ miRNA Expression Reporter Vector (Thermo Fisher Scientific, Inc) and named as pMIR-WT FOXO1. The mutant FOXO1 reporter was created by mutating the seed region of the miR-374a binding site of pMIR-WT FOXO1 using the site-directed mutagenesis kit (Takara Bio, Inc.) and named as pMIR-MT FOXO1. To perform the luciferase reporter assay, A172 cells were incubated in 48-well plates overnight at 37°C. Subsequently, the cells were cotransfected with luciferase pMIR-REPORT, Renilla luciferase pRL-TK vectors (Promega Corporation, Madison, WI, USA), and miR-374a mimic/inhibitor by using Lipofectamine 2000. After 48 h of transfection, the luciferase activities were measured using the Dual Luciferase Reporter Assay System (Promega Corporation) according to the manufacturer’s instruction.
+ Open protocol
+ Expand
5

Luciferase Assay for miR-519d Targeting TRIM32

Check if the same lab product or an alternative is used in the 5 most similar protocols
TRIM32 3ʹ UTR fragment was amplified from cDNA and cloned into the pMIR-REPORT™ miRNA Expression Reporter Vector (Thermo Fisher Scientific, Inc, Waltham, MA, USA) according to the manufacturer’s instruction. The recombinant plasmid was named as pMIR-wtTRIM32. pMIR-REPORT with mutant TRIM32 3ʹ UTR (pMIR-mtTRIM32) was obtained by using QuikChange Site-Directed Mutagenesis kit (Stratagene, Missouri, Texas, USA). After co-transfection with miR-519d mimics, pMIR-REPORT and Renilla luciferase pRL-TK vectors (Promega, Madison, WI, USA) for 48 hrs, luciferase activities were measured by using Dual-Luciferase Reporter assay system (Promega, Madison, WI, USA) according to the manufacturer’s instruction.
+ Open protocol
+ Expand
6

Validation of miR-15b Binding to GSK-3β 3' UTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
According to the manufacturer's instruction, the GSK-3β 3' UTR containing the seed region of the miR-15b binding site (UGCUGCUU) was cloned into the pGL3 luciferase reporter vector (Promega, Madison, USA). The recombined luciferase reporter vector was named as pGL3-wt GSK-3β. The mutant plasmid, pGL3-mt GSK-3β, was created through mutating the seed region of the miR-15b binding site (UGCUGCUU to UGCACCUU) using a site-directed mutagenesis kit (TaKaRa). For luciferase reporter analysis, cells were co-transfected with the pGL3-wt GSK-3β (or pGL3-mt GSK-3β), Renilla luciferase pRL-TK vectors (Promega) and the miR-15b mimics (or anti-miR-15b) using Lipofectamine 2000. After 48 h incubation, luciferase activities were measured by using the Dual-Luciferase Reporter assay system (Promega). Relative firefly luciferase activities were determined through normalization to Renilla luciferase activities in each well.
+ Open protocol
+ Expand
7

Luciferase Assay for KRas 3'UTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
The KRas 3′-UTR was cloned downstream of the firefly luciferase gene using the pGL3 Luciferase Reporter Vector Selector (Promega, Madison, WI) according to the manufacturer's instructions. To perform the luciferase reporter assay, NSCLC cells were incubated in 48-well plates overnight. The cells were then cotransfected with the pGL3 vectors carrying the KRas 3′-UTR, Renilla luciferase pRL-TK vectors (Promega), and the miR-202 mimics using Lipofectamine 2000. Forty-eight hours after transfection, the cells were collected and lysed. Luciferase activity was then measured using the Dual Luciferase Reporter Assay System (Promega). The relative firefly luciferase activity was normalized to Renilla luciferase activity.
+ Open protocol
+ Expand
8

miRNA Regulation of ADAM12 and PTEN

Check if the same lab product or an alternative is used in the 5 most similar protocols
The miR-29c, miR-17-5p, or scrambled miRNA mimic (100 nM); ADAM12 and PTEN 3'-UTR firefly luciferase report vectors (wild-type or mutated type); and the control vector containing the Renilla luciferase pRL-TK vector (Promega) were cotransfected into breast cancer cells by using Lipofectamine-2000 transfection reagent (Invitrogen), according to the manufacturer's protocol. The medium was changed after 16 h. For the luciferase reporter assay, cells were harvested after culturing for 48 h. Firefly and Renilla luciferase activities were consecutively measured using the Dual-Luciferase® Reporter Assay System (Promega). The experiments were performed in triplicate.
+ Open protocol
+ Expand
9

Dual-Luciferase Assay in C2C12 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
C2C12 cells were cotransfected with 40 ng of luciferase reporter vector, 20 ng of Renilla luciferase pRL-TK vector (Promega Corporation, Madison, WI, USA), and 342M or NC (20 nmol/l final) using Lipofectamine® 2000 (Invitrogen; Thermo Fisher Scientific, Inc.). The Firefly and Renilla luciferase activities were measured 48 h after the transfection with the Dual-Luciferase Reporter Assay System (Promega) using an FB12 Luminometer (Titertek-Berthold, Pforzheim, Germany). The Firefly luciferase activity was normalised to the Renilla luciferase activity.
+ Open protocol
+ Expand
10

Validating miR-133a-3p Regulation of MMP-9

Check if the same lab product or an alternative is used in the 5 most similar protocols
TargetScan version 7.2 (http://www.targetscan.org/vert_72/) was used to predict the potential targets of miR-133a-3p, and the binding sites between miR-133a and MMP-9. To confirm the association between miR-133a-3p and MMP-9, a dual-luciferase reporter assay was performed.
The wild-type and mutant 3′-UTR of MMP-9 (WT-MMP-9 and MUT-MMP-9, respectively) were cloned into a pmiR-RB-Report™ dual luciferase reporter gene plasmid vector (Guangzhou RiboBio Co., Ltd.) according to the manufacturer's protocol. hVSMCs were first seeded into 24-well plates (5×104 cells per well) and then co-transfected with 100 ng WT-MMP-9 or 100 ng MUT-MMP-9 and 100 nM miR-133a-3p mimic or 100 nM mimic control using Lipofectamine® 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) in accordance with the manufacturer's protocol, together with Renilla luciferase pRL-TK vector (Promega Corporation) as a control. Following transfection for 48 h, the relative luciferase activity was measured using the dual-luciferase reporter assay system (Promega Corporation), as per the manufacturer's protocol. All firefly luciferase activities were normalized to Renilla luciferase activity.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!